Dunad Therapeutics Revenue

Biotechnology Research • London, England, United Kingdom • 21-50 Employees

Dunad Therapeutics revenue & valuation

Annual revenue	$2,138,875
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$6,900,000
Total funding	$24,000,000

Key Contacts at Dunad Therapeutics

Ahmed S.A. Mady

Associate Director Of Biochemistry And Biophysics

Barry Teobald

Director Of Medicinal Chemistry

Mirco Meniconi

Director Of Computational Sciences

Lou Chupak

Director Of Medicinal Chemistry

Antony J. Burton

Associate Director, Chemical Biology & Proteomics

Alison Davis

Director Biology

Company overview

Headquarters	Cambridge, EC2N 1AR, GB
Website	dunadtx.com
NAICS	541714
Keywords	Oncology, Drug Development, Cns Disease, Covalent Chemistry
Founded	2020
Employees	21-50
Socials

Dunad Therapeutics Email Formats

Dunad Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@dunadtx.com), used 63.2% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@dunadtx.com	63.2%
{first name}.{last name}	john.doe@dunadtx.com	36.8%

About Dunad Therapeutics

Dunad Therapeutics combines proprietary, tunable covalent chemistry with a deep understanding of disease biology to discover and develop transformational medicines that selectively and durably target disease drivers.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director

Entry

Senior

Employees by Department

Dunad Therapeutics has 12 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Dunad Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-12-02	4	$24,000,000

Funding Insights

$24,000,000

Total funding amount

$24,000,000

Most recent funding amount

Number of funding rounds

Dunad Therapeutics Tech Stack

Discover the technologies and tools that power Dunad Therapeutics's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Slick

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

jQuery

JavaScript libraries

PHP

Programming languages

Google AdSense

Advertising

WordPress

Blogs

Google Analytics

Analytics

Yoast SEO

SEO

Microsoft Clarity

Analytics

Frequently asked questions

Dunad Therapeutics is located in London, England, GB.

Dunad Therapeutics generates an estimated annual revenue of $2,138,875. This revenue figure reflects the company's market position and business performance in its industry.

Dunad Therapeutics has an estimated valuation of $6,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Dunad Therapeutics was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Dunad Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Dunad Therapeutics has raised a total of $24,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Dunad Therapeutics

Ahmed S.A. Mady

Associate Director Of Biochemistry And Biophysics

Barry Teobald

Director Of Medicinal Chemistry

Mirco Meniconi

Director Of Computational Sciences

Lou Chupak

Director Of Medicinal Chemistry

Antony J. Burton

Associate Director, Chemical Biology & Proteomics

Alison Davis